ACW 5.71% 7.4¢ actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-5

  1. 8,400 Posts.
    lightbulb Created with Sketch. 1383
    @krispi thanks for posting the article.

    For AD treatment, the intention is that Xanamem be part of a drug cocktail, not administered on its own.

    For cognitive decline in other indications, I don't know if it would be administered on its own.
    Last edited by IndexInvestor: 08/05/20
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.